0001181431-12-041552.txt : 20120720 0001181431-12-041552.hdr.sgml : 20120720 20120720165921 ACCESSION NUMBER: 0001181431-12-041552 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120709 FILED AS OF DATE: 20120720 DATE AS OF CHANGE: 20120720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Norton David Y CENTRAL INDEX KEY: 0001529193 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 12972824 MAIL ADDRESS: STREET 1: ONE TOWER CENTER BLVD. CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd351432.xml FORM 4 X0306 4 2012-07-09 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001529193 Norton David Y ONE TOWER CENTER BLVD. FLOOR 14 EAST BRUNSWICK NJ 08816 1 0 0 0 Common Stock, $0.01 par value 2012-07-09 4 A 0 62035 .56 A 69284 D Option to purchase The right to receive these shares is purs .56 2012-07-09 4 A 0 82458 .56 D 2012-08-22 2022-07-09 Common Stock, $0.01 par value 82458 82458 D The right to receive these shares is pursuant to a restricted stock unit grant, 100% of which shall vest 30 days from the first anniversary of the grant date. These stock options will vest as follows: 11,481 on August 22, 2012, 23,659 on November 22, 2012, 23,659 on February 22, 2013, and 23,659 on the earlier of May 22, 2013 or the Company's 2013 Annual Meeting of Stockholders. Irina Ishak as Attorney-In-Fact for David Y. Norton 2012-07-20